Pamorelin (Trelstar® )is going to become available in the Philippines. Pamorelin, and Decapeptyl® will be made available to urologists and oncologists who treat men with advanced prostate cancer. It will be available in one, three and six month formulations. Pamorelin is an agonist analogue of the natural gonadotropin-releasing hormone (GnRH). It is designed to chemically castrate men so that their advanced prostate cancer will not have the male androgens needed to feed the prostate cancer.
Real Life Issues About Abiraterone Acetate (Zytiga) Prior to Chemotherapy – Unanticipated Real-World Clinical Experience Worth Noting
Researchers in Hong Kong wanted to confirm the efficacy of abiraterone acetate (Zytiga) used prior to chemotherapy that had been shown in the trial setting. In their analysis they came up short; raising some very significant concerns about Zytiga’s efficacy when used prior to chemotherapy. They reviewed the clinical records of men with metastatic castrate resistant prostate cancer (mCRPC) who had been treated with Zytiga from all 6 public oncology centers in Hong Kong between August 2011 and December 2014. They evaluated their treatment efficacy, its determinants and toxicities. They evaluated 110 men with castrate resistant prostate cancer of whom [...]